(1-Methyl-1H-indol-2-yl)methanamine is primarily used in the field of organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of various bioactive compounds, particularly those targeting neurological and psychiatric disorders. The indole structure of this compound makes it valuable for designing molecules that interact with serotonin receptors, which are crucial in regulating mood, anxiety, and cognitive functions. Additionally, it is utilized in the synthesis of potential drug candidates for treating conditions like depression, schizophrenia, and migraines. Its versatility also extends to the creation of novel chemical entities for studying biochemical pathways and drug discovery processes.